Citius Pharmaceuticals (CTXR) Acquires Dr. Reddy's (RDY) Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indicatio Sep 7, 2021 07:34AM
Citius Pharmaceuticals Acquires Dr. Reddy's Laboratories' License for Late-Phase 3 Oncology Immunotherapy (E7777) for the Treatment of Cutaneous T-Cell Lymphoma and other Cancer Indications Sep 7, 2021 07:30AM